World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
50
Citations
12473
World Ranking
5660
National Ranking
457

Best Publications

  • Huntington disease: natural history, biomarkers and prospects for therapeutics

    Christopher A Ross;Elizabeth Hoppes Aylward;Edward J Wild;Douglas R Langbehn

  • Huntington disease

    Unknown

  • A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease

    Maria Björkqvist;Edward J. Wild;Jenny Thiele;Aurelio Silvestroni

  • Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

    Bridel C;van Wieringen Wn;Zetterberg H;Tijms Bm

  • Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities.

    Sarah J. Tabrizi;Michael D. Flower;Christopher A. Ross;Edward J. Wild

  • Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis

    Lauren M Byrne;Filipe B. Rodrigues;Kaj Blennow;Kaj Blennow;Alexandra Durr

  • Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities

    Unknown

  • Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

    Davina J Hensman Moss;Antonio F Pardiñas;Douglas Langbehn;Kitty Lo

  • Therapies targeting DNA and RNA in Huntington's disease.

    Edward J Wild;Sarah J Tabrizi

  • Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington’s disease patients

    Edward J. Wild;Roberto Boggio;Douglas Langbehn;Nicola Robertson

  • Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates.

    Annette Dalrymple;Edward J Wild;Richard Joubert;Kirupa Sathasivam

  • Rapid eye movement sleep disturbances in Huntington disease.

    Isabelle Arnulf;Jørgen Nielsen;Ebba Lohmann;Johannes Schieffer

  • Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY

    Michael Orth;O J Handley;C Schwenke

  • C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies

    Davina J. Hensman Moss;Mark Poulter;Jon Beck;Jason Hehir

  • Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington’s disease

    Lauren M. Byrne;Filipe B. Rodrigues;Eileanor B. Johnson;Peter A. Wijeratne

  • Mutant huntingtin fragmentation in immune cells tracks Huntington’s disease progression

    Andreas Weiss;Ulrike Träger;Edward J. Wild;Stephan Grueninger

  • MSH3 modifies somatic instability and disease severity in Huntington's and myotonic dystrophy type 1.

    Michael Flower;Vilija Lomeikaite;Marc Ciosi;Sarah Cumming

  • Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.

    Rachael I Scahill;Paul Zeun;Katherine Osborne-Crowley;Katherine Osborne-Crowley;Eileanoir B Johnson

  • Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood

    Heike Runne;Alexandre Kuhn;Edward J. Wild;Wirahpati Pratyaksha

  • Targets for future clinical trials in Huntington's disease: What's in the pipeline?

    Edward J. Wild;Sarah J. Tabrizi

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: